Common name
methylhydrazine
IUPAC name
methylhydrazine
SMILES
CNN
Common name
methylhydrazine
IUPAC name
methylhydrazine
SMILES
CNN
INCHI
InChI=1S/CH6N2/c1-3-2/h3H,2H2,1H3
FORMULA
CH6N2
Common name
methylhydrazine
IUPAC name
methylhydrazine
Molecular weight
46.072
clogP
-0.952
clogS
0.266
Frequency
0.0007
HBond Acceptor
0
HBond Donor
3
Total PolarSurface Area
38.05
Number of Rings
0
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00643 | Phenelzine |
|
Antidepressive Agents; Monoamine Oxidase Inhibitors; Nervous System; Antidepressants; Psychoanaleptics; Monoamine Oxidase Inhibitors, Non-Selective; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of major depressive disorder. Has also been used with some success in the management of bulimia nervosa. |
| FDBD01014 | Procarbazine |
|
Antineoplastic Agents; Immunosuppressive Agents; Antineoplastic and Immunomodulating Agents; Methylhydrazines; | For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin's disease. |
2 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 2i5j_ligand_1_0.mol2 | 2i5j | 1 | -5.08 | CNN | 3 |
| 4bhi_ligand_2_2.mol2 | 4bhi | 0.6 | -5.97 | [N+](C)(C)(C)[NH+](C)C | 7 |
| 4bhi_ligand_1_2.mol2 | 4bhi | 0.6 | -5.83 | [N+](C)(C)(C)[NH2+]C | 6 |
| 2gpp_ligand_1_0.mol2 | 2gpp | 0.375 | -5.39 | N(C)NC=O | 5 |
| 2fq6_ligand_1_4.mol2 | 2fq6 | 0.375 | -5.36 | N(C=O)NC | 5 |
| 2cem_ligand_2_38.mol2 | 2cem | 0.375 | -5.25 | N(C=O)[NH2+]C | 5 |
| 2cem_ligand_2_45.mol2 | 2cem | 0.375 | -5.22 | C[NH2+]NC=O | 5 |
| 2cen_ligand_2_38.mol2 | 2cen | 0.375 | -5.22 | C[NH2+]NC=O | 5 |
| 2cen_ligand_2_45.mol2 | 2cen | 0.375 | -5.18 | [NH2+](NC=O)C | 5 |
100 ,
11
